The Kindle Scribe features a sharp 300ppi E Ink display that’s glare-free and supports adjustable color temperatures, making ...

Its shares are up 30% since it raised $125 million in its initial public offering Friday.

The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most ...

If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: Samantha Mangino / ...

The 3rd Generation Amazon Kindle Scribe features an expanded 11-inch E Ink Oxide display, a thinner 5.4 mm profile, a lighter ...

Amazon does not have long to release the Kindle Scribe Colorsoft and the Kindle Scribe 2025 model with a front-light. Amazon announced three new Kindle Scribe e-notebooks at the end of September and ...

Scribe Therapeutics, a clinical-stage developer of gene therapies for heart disease, is seeking to raise as much as $107.2 million through a U.S. initial public offering. The Alameda, California-based ...

The Kindle Scribe Without Front Light should be an ideal e-ink notebook, but it's limits are hard to ignore. Find out more in this review.

Kindle is arguably the most recognizable e-reader on the market. Amazon has been producing the devices for years, and there ...

Workflow software startup Scribe has raised $75 million and achieved unicorn status, as it aims to reimagine AI integration ...

Sanofi (SNY) and Eli Lilly (LLY)-backed Scribe Therapeutics (SCTX) stock surges nearly 50% after an upsized IPO that raised ...